Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BAH domain and coiled-coil containing protein 1 (BAHCC1) is a chromatin-associated protein characterized by a conserved bromo-adjacent homology (BAH) domain that specifically recognizes trimethylated histone H3 lysine 27 (H3K27me3)[1][3]. Through interaction with H3K27me3, BAHCC1 acts as a transcriptional corepressor, enforcing gene silencing of Polycomb target genes. It recruits additional repressive cofactors and links H3K27me3 recognition with histone deacetylation through interaction with HDACs, modulating chromatin structure and gene expression. BAHCC1 is overexpressed in some cancers (notably acute leukemia), and its depletion can derepress tumor suppressor and differentiation genes, highlighting its role in oncogenesis. Animal studies show that functional disruption of BAHCC1 interferes with normal development, underlining its crucial role in cell fate determination and chromatin organization[1][3][5][6].
Drugs or molecules would be expected to act as inhibitors or disruptors of BAHCC1's interaction with H3K27me3 or associated corepressor complexes (mechanism characterized structurally and biochemically, but no current approved drugs)[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BAH domain and coiled-coil containing protein 1 (BAHCC1).